Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Digoxigenin

Digoxigenin

1672-46-4

DISCOVER
Disopyramide

Disopyramide

3737-09-5

DISCOVER
Dasatinib Hydrate Impurity H

Dasatinib Hydrate Impurity H

302964-24-5

DISCOVER
DHBMA

DHBMA

144889-50-9

DISCOVER
rac-(cis/trans) Donepezil N-Oxide

rac-(cis/trans) Donepezil N-Oxide

120013-84-5

DISCOVER
2,3-Dihydro-5,6-dimethoxy-2-[(1-oxido-4-pyridinyl)methylene]-1H-inden-1-one

2,3-Dihydro-5,6-dimethoxy-2-[(1-oxido-4-pyridinyl)methylene]-1H-inden-1-one

896134-06-8

DISCOVER
3-Hydroxy Donepezil

3-Hydroxy Donepezil

2097683-67-3

DISCOVER
Diatrizoic acid 2H2O

Diatrizoic acid 2H2O

50978-11-5

DISCOVER
Dikegulac acid

Dikegulac acid

18467-77-1

DISCOVER
Detomidine Hydrochloride

Detomidine Hydrochloride

90038-01-0

DISCOVER
Detomidine Hydrochloride

Detomidine Hydrochloride

90038-01-0

DISCOVER
Detomidine Hydrochloride

Detomidine Hydrochloride

90038-01-0

DISCOVER